Article info

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Authors

  • Matthew J Carr Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester, UKNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Alison K Wright Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester, UKDivision of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Lalantha Leelarathna Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UKDiabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Hood Thabit Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UKDiabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Nicola Milne Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Naresh Kanumilli Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Darren M Ashcroft Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester, UKNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Martin K Rutter Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester, UKDiabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Matthew J Carr, Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester M13 9PL, UK; matthew.carr{at}manchester.ac.uk
View Full Text

Citation

Carr MJ, Wright AK, Leelarathna L, et al
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Publication history

  • Received April 29, 2021
  • Accepted August 25, 2021
  • First published October 12, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.